ANN B ZIMRIN
Medical Practice at Witherspoon Rd, Baltimore, MD

License number
DC MD30917
Issued Date
May 23, 1998
Expiration Date
Dec 31, 2004
Category
MEDICINE
Type
MEDICINE AND SURGERY
Address
Address
115 Witherspoon Rd, Baltimore, MD 21212

Personal information

See more information about ANN B ZIMRIN at radaris.com
Name
Address
Phone
Ann Zimrin, age 68
115 Witherspoon Rd, Baltimore, MD 21212
(410) 433-3887
Ann B Zimrin, age 68
115 Witherspoon Rd, Baltimore, MD 21212
(410) 433-3887
Ann B Zimrin, age 68
1235 Crows Foot Rd, Marriottsville, MD 21104

Organization information

See more information about ANN B ZIMRIN at bizstanding.com

Ann B Zimrin MD

22 S Greene St #1, Baltimore, MD 21201

Categories:
Internal Medicine Physicians & Surgeons, Pediatrics Physicians & Surgeons
Phone:
(410) 328-7450 (Phone)

Professional information

Ann Zimrin Photo 1

Ann Zimrin, Baltimore MD

Work:
University of Maryland
22 S Greene St, Baltimore, MD 21263


Ann B Zimrin Photo 2

Dr. Ann B Zimrin, Baltimore MD - MD (Doctor of Medicine)

Specialties:
Hematology, Medical Oncology, Oncology
Address:
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
(410) 328-6971 (Phone), (410) 328-8326 (Fax)
University Maryland Cancer Ctr
22 S Greene St SUITE 1, Baltimore 21201
(410) 328-7450 (Phone)
Languages:
English
Hospitals:
UNIVERSITY OF MARYLAND MEDICAL CENTER
22 S Greene St, Baltimore 21201
University Maryland Cancer Ctr
22 S Greene St SUITE 1, Baltimore 21201
Baltimore Washington Medical Center
301 Hospital Dr, Glen Burnie 21061
University of Maryland Medical Center
22 South Greene St, Baltimore 21201
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1981
University Calif
Graduated: 1984
University Of Pennsylvania


Ann Zimrin Photo 3

Therapeutic And Diagnostic Methods And Compositions Based On Jagged/Notch Proteins And Nucleic Acids

US Patent:
6716974, Apr 6, 2004
Filed:
May 24, 2000
Appl. No.:
09/579536
Inventors:
Thomas Maciag - Freeport ME
Ann B. Zimrin - Baltimore MD
Deena J. Small - Scarborough ME
Igor A. Prudovsky - Old Orchard Beach ME
Assignee:
Maine Medical Center Research Institute - Scarborough ME
International Classification:
C07H 2104
US Classification:
536 235, 435 691, 435 991, 4352542, 4353201
Abstract:
This invention relates to therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids, and on their role in the signaling pathway relating to endothelial cell migration and/or differentiation. In addition, this invention provides a substantially purified Jagged protein, as well as a substantially purified nucleic acid or segment thereof encoding Jagged protein, or a functionally equivalent derivative, or allelic or species variant thereof. Further, this invention provides a substantially purified soluble Jagged protein and a substantially purified nucleic acid encoding same as well as a recombinant cell comprising a nucleic acid encoding a soluble Jagged protein. Soluble Jagged provides further therapeutic and diagnostic methods relating to diseases, disorders, and conditions involving Jagged/Notch signaling including, inter alia, angiogenesis, differentiation, and control of gene expression.


Ann Zimrin Photo 4

Therapeutic And Diagnostic Methods And Compositions Based On Jagged/Notch Proteins And Nucleic Acids

US Patent:
7304138, Dec 4, 2007
Filed:
Aug 28, 2003
Appl. No.:
10/650650
Inventors:
Thomas Maciag - Freeport ME, US
Ann B. Zimrin - Baltimore MD, US
Deena J. Small - Scarborough ME, US
Igor A. Prudovsky - Old Orchard Beach ME, US
Assignee:
Maine Medical Center Research Institute - Scarborough ME
International Classification:
C07K 14/435, C07K 14/515
US Classification:
530350, 530402, 536 235, 514 12
Abstract:
This invention relates to therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids, and on their role in the signaling pathway relating to endothelial cell migration and/or differentiation. In addition, this invention provides a substantially purified Jagged protein, as well as a substantially purified nucleic acid or segment thereof encoding Jagged protein, or a functionally equivalent derivative, or allelic or species variant thereof. Further, this invention provides a substantially purified soluble Jagged protein and a substantially purified nucleic acid encoding same as well as a recombinant cell comprising a nucleic acid encoding a soluble Jagged protein. Soluble Jagged provides further therapeutic and diagnostic methods relating to diseases, disorders, and conditions involving Jagged/Notch signaling including, inter alia, angiogenesis, differentiation, and control of gene expression.